Everett Harris & Co
- SEC CIK
- 0001009254
- Latest filing
- Aug 3, 2026
CASI holding history
CASI Pharmaceuticals, Inc (DE) in every 13F filed by Everett Harris & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CASI overviewAll 13F holders of CASIFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −1,000−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q1 2022 | 10,002 | $8.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 10,002 | $8.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 10,002 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 10,002 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 10,002 | $24.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.